Algo version: 0.98b
Novo Nordisk AS is listed at the NYSE Exchange
Novo Nordisk AS [NVO]
NYSE Sector: Healthcare Industry:Biotechnology

Is Novo Nordisk AS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Novo Nordisk AS pays dividends. Last time was Monday 26th of August 2024 where the investors holding the stock on Friday 16th of August 2024 were paid $0.07584705 per share. Over the last 55 times between 1982 and 2024, Novo Nordisk AS has paid $6.50220705 with an average of $0.12 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Novo Nordisk AS 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $27.23, you would have made a profit of $78.04 per share or 286.60%

Yes, the average daily trading liquidity for Novo Nordisk AS is $4.53 million. You should therefore be able to get in and out of your positions relatively fast.

Novo Nordisk AS has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.08, the company's ability to pay off the debt is good. Novo Nordisk AS has a very good net profit margin of 35.01% and should have very high tolerances against inflation.

We have calculated the inflation risk for Novo Nordisk AS to be low [0.15 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.